Nearly 90 Xarelto Lawsuits Added to Federal Blood Thinner Litigation since December, Bernstein Liebhard LLP Reports
New York, NY (PRWEB) January 18, 2015 -- A federal litigation established just last month in the U.S. District Court, Eastern District of Louisiana now includes almost 90 Xarelto lawsuits (http://www.xareltolawsuit2015.com/) that allege similar injuries caused by the blood thinner, Bernstein Liebhard LLP reports.
A Case List updated on January 15th shows 86 filings in the multidistrict litigation established for claims that allege life-threatening and incontrollable episodes of internal bleeding, as well as other complications. This court update comes shortly after a panel of federal judges voted in December 2014 to transfer similar Xarelto lawsuits to the Eastern District of Louisiana for pretrial proceedings. Plaintiffs in cases involving the blood thinner accuse its manufacturer of failing to adequately warn about complications that allegedly stem from use of its product. (In Re: Xarelto Products Liability Litigation, No. 2592)
“Our Firm is representing plaintiffs in Xarelto lawsuits who were allegedly harmed by this blood thinner. We are not surprised to see the newly-established Xarelto litigation continuing to move forward, as we hear regularly from individuals who also claim to have experienced internal bleeding and other side effects allegedly related to its use,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is currently evaluating potential Xarelto lawsuits on behalf of individuals who allegedly sustained life-threatening episodes of internal bleeding, strokes, deep vein thrombosis and/or pulmonary embolism allegedly due to use of Xarelto.
Xarelto Lawsuits
According to court documents, all the blood thinner lawsuits now pending in the Eastern District of Louisiana accuse Bayer Healthcare and the Johnson & Johnson subsidiary, Janssen Pharmaceuticals of wrongfully promoting the blood thinner as a convenient alternative to the decades-old treatment, warfarin. This medication is used for similar purposes, but requires users to regularly undergo blood level monitoring and adhere to dietary restrictions. Xarelto does not ask patients to take such measures, its manufacturer has insisted since its U.S. Food and Drug Administration (FDA) approval in 2011, but its use may be tied to serious episodes of internal bleeding, according to plaintiffs.*
Xarelto bleeding complications may become life-threatening since there is no available antidote to reverse them, plaintiffs further allege, which the drug’s manufacturer allegedly concealed from consumers in its marketing efforts. Warfarin has also been tied to internal bleeding episodes, but they can be reversed via the administration of Vitamin K.
Patients who allegedly sustained life-threatening episodes of Xarelto bleeding and other complications may be eligible to receive compensation for injury-related damages. Learn more about Xarelto internal bleeding complications by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free and confidential case review.
*fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, March 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.xareltolawsuit2015.com/
https://plus.google.com/115936073311125306742?rel=author
Felecia L. Stern, Xarelto Lawsuit Claims Center, http://www.xareltolawsuit2015.com/, +1 800-511-5092, [email protected]
Share this article